ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000182586.3	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.011979672	Resistant
ENSG00000182586.3	ABT-263 (navitoclax)	Sarcoma	0.020697378	Sensitive